The addition of cisplatin to standard-of-care radiation ther

1. For patients with localized endometrial cancer recurrence, adding cisplatin to radiation therapy did not appear to improve progression-free survival when compared to radiation therapy alone. 2. For patients with localized endometrial cancer recurrence, adding cisplatin to radiation therapy resulted in higher rates of acute toxicity, when compared to radiation therapy alone. Evidence Rating Level:

Related Keywords

, Rating Level , Chemoradiation , Cisplatin , Endometrial Cancer , Chronic Disease , Oncology ,